Columns CHIMIA 2014, 68, Nr. 6 doi:[removed]chimia[removed]Chimia[removed]–451

First Page		Document Content
Date: 2014-09-24 02:52:54 Debiopharm HES-SO Peptidomimetic Sion Switzerland Bioresource engineering HEIG-VD Valais Peptide École Polytechnique Fédérale de Lausanne Cantons of Switzerland Switzerland Biopharmaceuticals		Columns CHIMIA 2014, 68, Nr. 6 doi:[removed]chimia[removed]Chimia[removed]–451 Add to Reading List Source URL: www.swissbiotech.org Download Document from Source Website File Size: 313,77 KB Share Document on Facebook

	Debiopharm Group™ est un groupe international de quatre sociétés biopharmaceutiques basé en Suisse, actif dans les domaines du développement de médicaments, de la fabrication de médicaments exclusifs selon les BP DocID: 1r2k6 - View Document
	BIOTECH’S MOST RESPECTED NEWS SOURCE FOR MORE THAN 20 YEARS THURSDAY MARCH 15, 2012 VOLUME 23 , NO. 51 DocID: 19ZND - View Document
	Columns CHIMIA 2014, 68, Nr. 6 doi:[removed]chimia[removed]Chimia[removed]–451 DocID: QkF8 - View Document
	PDF Document DocID: Q6jk - View Document
	PRESS RELEASE Debiopharm Group™ and TCG Lifesciences Ltd. announce successful completion of first phase of research collaboration on discovery of novel antibiotics Lausanne, Switzerland and Kolkata, India – June 24 2 DocID: PORs - View Document